Skip to main content
Mind Medicine (MindMed) Inc. logo

Mind Medicine (MindMed) Inc. — Investor Relations & Filings

Ticker · MNMD ISIN · CA60255C8850 LEI · 549300QY8KN1O6RPFJ13 US Manufacturing
Open in API
Filings indexed 439 across all filing types
Latest filing 2025-05-27 Board/Management Inform…
Country CA Canada
Listing US MNMD

About Mind Medicine (MindMed) Inc.

https://ir.mindmed.co/

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders. The company's research and development pipeline focuses on innovative treatments derived from psychedelics and other novel compounds. These candidates, which include substances with and without acute perceptual effects, are designed to target key neurotransmitter pathways. MindMed's mission is to deliver therapies that address unmet patient needs in psychiatry, with clinical programs investigating treatments for conditions such as Major Depressive Disorder.

Recent filings

Filing Released Lang Actions
FORM 8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated May 27, 2025, which is a Current Report pursuant to the Securities Exchange Act of 1934. The content focuses on the appointment of a new Chief Financial Officer, Brandi L. Roberts, including details about her employment agreement, compensation, and severance terms. There is no financial data or comprehensive report content; rather, it is an announcement of a management change. The document also includes a press release as an exhibit related to this appointment. According to the filing definitions, announcements of changes in the company's board of directors or senior management fall under Board/Management Information (MANG). Therefore, this document is best classified as MANG with high confidence.
2025-05-27 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-05-15 English
10-Q
Interim / Quarterly Report Q1 2025
2025-05-08 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated May 8, 2025, reporting the issuance of a press release announcing financial results for the first quarter ended March 31, 2025, and information about a conference call. The text states that the press release is furnished as an exhibit and incorporated by reference, and the document itself does not contain detailed financial statements or substantive financial data, only a summary and reference to the press release. The document length is 3792 characters, which is relatively short and consistent with an announcement rather than a full earnings release. According to the rules, a short document announcing financial results and referencing a press release is classified as an Earnings Release (ER) if it contains key highlights only. Since this is a Form 8-K announcing quarterly financial results and a press release, it fits the Earnings Release category rather than a full Interim Report or Annual Report. Therefore, the correct classification is ER with high confidence.
2025-05-08 English
Regulatory Filings 2025
Regulatory Filings
2025-05-05 English
ARS
Annual Report
2025-04-23 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.